These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34648616)

  • 1. SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies.
    Hornick MG; Olson ME; Jadhav AL
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):1-12. PubMed ID: 34648616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Covid-19 attack our nervous system?
    Abdel Hafez SMN
    J Chem Neuroanat; 2021 Nov; 117():102006. PubMed ID: 34324964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
    Romero A; Ramos E; López-Muñoz F; Gil-Martín E; Escames G; Reiter RJ
    Cell Mol Neurobiol; 2022 Apr; 42(3):489-500. PubMed ID: 32772307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
    Adinolfi LE; Nevola R; Lus G; Restivo L; Guerrera B; Romano C; Zampino R; Rinaldi L; Sellitto A; Giordano M; Marrone A
    World J Gastroenterol; 2015 Feb; 21(8):2269-80. PubMed ID: 25741133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of potential therapeutic agents to treat COVID-19.
    Dong X; Tian Z; Shen C; Zhao C
    Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health.
    Raony Í; de Figueiredo CS; Pandolfo P; Giestal-de-Araujo E; Oliveira-Silva Bomfim P; Savino W
    Front Immunol; 2020; 11():1170. PubMed ID: 32574266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
    Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
    Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 invasion of the central nervous: a brief review.
    Siddiqui R; Mungroo MR; Khan NA
    Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
    Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
    J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.